Regeneron Pharmaceuticals, Inc. (BVL:REGN)
736.90
0.00 (0.00%)
At close: Feb 18, 2026
8.35% (1Y)
| Market Cap | 272.12B +2.2% |
| Revenue (ttm) | 48.25B +1.0% |
| Net Income | 15.16B +2.1% |
| EPS | 139.55 +8.2% |
| Shares Out | n/a |
| PE Ratio | 17.96 |
| Forward PE | 16.40 |
| Dividend | 12.61 (1.71%) |
| Ex-Dividend Date | Nov 20, 2025 |
| Volume | n/a |
| Average Volume | n/a |
| Open | n/a |
| Previous Close | 736.90 |
| Day's Range | n/a |
| 52-Week Range | 564.51 - 750.80 |
| Beta | n/a |
| RSI | 73.21 |
| Earnings Date | Jan 30, 2026 |